7th Aug 2020 11:02
Biopharma Credit PLC - life sciences debt investment trust - Has received notice of prepayment for USD150 million senior secured loan from Novocure Ltd. Expects to receive USD154.8 million from the portfolio firm. Meanwhile, Global Blood Therapeutics Inc has provided notice to lenders of intent to draw second tranche of term loan for USD75 million before end of 2020. This would increase Biopharma's investment to USD82.5 million from USD41.3 million.
Current stock price: USD1.01
Year-to-date change: down 1.0%
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Biopharma Cred.